Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ

被引：6
|
作者：
Obeng-Gyasi, Samilia [1 ]
Ong, Cecilia [1 ]
Hwang, E. Shelley [1 ]
机构：
[1] Duke Univ, Med Ctr, 465Seeley Mudd Bldg, Durham, NC 27710 USA
来源：
CHINESE CLINICAL ONCOLOGY | 2016年 / 5卷 / 03期
关键词：
Ductal carcinoma in situ (DCIS); lobular neoplasia (LN); lobular carcinoma in situ (LCIS);
D O I：
10.21037/cco.2016.04.02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The management of in situ lesions ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) continues to evolve. These diagnoses now comprise a large burden of mammographically diagnosed cancers, and with a global trend towards more population-based screening, the incidence of these lesions will continue to rise. Because outcomes following treatment for DCIS and LCIS are excellent, there is emerging controversy about what extent of treatment is optimal for both diseases. Here we review the current approaches to the diagnosis and treatment of both DCIS and LCIS. In addition, we will consider potential directions for future management of these lesions.
引用
收藏
页数：14
相关论文
共 50 条
  • [1] Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast
    Wood, WC
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (04) : 446 - 452
  • [2] The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
    Lakhani, Sunil R.
    Audretsch, Werner
    Cleton-Jensen, Anne-Marie
    Cutuli, Bruno
    Ellis, Ian
    Eusebi, Vincenzo
    Greco, Marco
    Houslton, Richard S.
    Kuhl, Christiane K.
    Kurtz, John
    Palacios, Jose
    Peterse, Hans
    Rochard, France
    Rutgers, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) : 2205 - 2211
  • [3] Lobular carcinoma in situ - correlation of grading with invasive carcinoma and with ductal carcinoma in situ
    Amalinei, C.
    Balan, R.
    Pricop, F.
    Cotutiu, C.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 190 - 191
  • [4] Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ
    Clauser, Paola
    Marino, Maria A.
    Baltzer, Pascal A. T.
    Bazzocchi, Massimo
    Zuiani, Chiara
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (03) : 335 - 346
  • [5] Pleomorphic Lobular Carcinoma In Situ: Molecular Signature in Comparison to High-Grade Ductal Carcinoma In Situ and Classical Lobular Carcinoma In Situ
    Bakkar, Rania
    Vail, Eric
    Lopategui, Jean
    Engman, David
    Dadmanesh, Farnaz
    [J]. MODERN PATHOLOGY, 2018, 31 : 46 - 47
  • [6] Pleomorphic Lobular Carcinoma In Situ: Molecular Signature in Comparison to High-Grade Ductal Carcinoma In Situ and Classical Lobular Carcinoma In Situ
    Bakkar, Rania
    Vail, Eric
    Lopategui, Jean
    Engman, David
    Dadmanesh, Farnaz
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 46 - 47
  • [7] Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast
    Buerger, H
    Simon, R
    Schäfer, KL
    Diallo, R
    Littmann, R
    Poremba, C
    van Diest, PJ
    Dockhorn-Dworniczak, B
    Böcker, W
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (03): : 118 - 121
  • [8] Mixed apocrine/endocrine ductal carcinoma in situ of the breast coexistent with lobular carcinoma in situ
    Coyne, JD
    Dervan, PA
    Barr, L
    Baildam, AD
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (01) : 70 - 73
  • [9] Management of ductal carcinoma in situ
    Talamonti, MS
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1996, 12 (05): : 300 - 313
  • [10] Management of ductal carcinoma in situ
    Hwang, ES
    Esserman, LJ
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 1999, 79 (05) : 1007 - +
12345